Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands

Autor: Kwakman, Johannes J.M., Vink, G., Vestjens, J. H., Beerepoot, L. V., de Groot, J. W., Jansen, R. L., Opdam, F. L., Boot, H., Creemers, G. J., van Rooijen, J. M., Los, M., Vulink, A. J.E., Schut, H., van Meerten, E., Baars, A., Hamberg, P., Kapiteijn, E., Sommeijer, D. W., Punt, C. J.A., Koopman, M., Sub Tolakker, Afd Pedagogiek in diverse samenlevingen, Methodology and statistics for the behavioural and social sciences

Publikováno v: International Journal of Clinical Oncology, 23(3), 482-489. Springer
International journal of clinical oncology / Japan Society of Clinical Oncology, 23(3), 482-489. Springer Japan
International Journal of Clinical Oncology, 23(3), 482
International Journal of Clinical Oncology
International Journal of Clinical Oncology, 23(3), 482-489. Springer Japan
International Journal of Clinical Oncology, 23(3), 482-489

BACKGROUND The RECOURSE trial showed clinical efficacy for trifluridine/tipiracil for refractory metastatic colorectal cancer patients. We assessed the feasibility and effectiveness of trifluridine/tipiracil in daily clinical practice in The Netherla

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a1d201f8c6a1fad14ef67a08d9f4859
https://cris.maastrichtuniversity.nl/en/publications/a53c0038-9aa8-4725-9fdc-a571e30b0397